在癌症治疗中:基于金属的医学的新前沿
Manoj R Kumbhare1, Rutuja Porje2, Arshad Shaikh2
1Professor, Department of Pharmaceutical Chemistry, SMBT College of Pharmacy, Nashik, India.
概括
(III) 复合物为精密瘤学提供了一个多功能平台,使得癌症诊断和治疗能够同时进行. 这些复合物表现出强大的抗癌活性,与传统疗法相比,毒性降低.
科学领域:
- * 无机化学 无机化学
- * 材料科学 材料科学
- * 纳米医学是一种纳米医学.
背景情况:
- * (III) 复合物具有独特的光物理,氧化还原和结构性质,是针对癌症治疗的理想选择.
- * 传统化疗在特异性和毒性方面面临局限性,这推动了对先进治疗剂的需求.
- *精确瘤学需要创新的解决方案,同时进行诊断和治疗.
研究的目的:
- * 审查 (III) 复合物的合成和瘤学中的生物医学应用的最新进展.
- * 突出复合物的结构多样性和细胞机制.
- * 探索新兴的策略,以提高基于的癌症疗法.
主要方法:
- *对过去五年内发表的研究进行了全面的文献综述.
- *分析各种复杂结构,包括循环金属化,单核和基于纳米粒子的配方.
- * 检查细胞吸收,贩运和亚细胞积累模式.
主要成果:
- * 复合体通过ROS生成,线粒体损伤和DNA分裂来选择性杀死癌细胞.
- *纳米载体工程改善了复合物的药理动力学,生物降解性,并降低了系统性毒性.
- *新的策略,如瘤微环境响应性输送和组合疗法,显示出显著的前景.
结论:
- * (III) 复合物是精密瘤学的强大而适应性的平台.
- * 这些综合体为癌症治疗提供多模式的方法,整合成像和治疗.
- * 基于的疗法显示出强大的转化潜力,可以改善癌症患者的治疗结果.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K


